Ngā hua rapu - Frederik Nevens

Whakamahine hua
  1. 1
    Budd‐Chiari syndrome

    Budd‐Chiari syndrome mā Pieter Martens, Frederik Nevens

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Primary biliary cholangitis as a roadmap for the development of novel treatments for cholestatic liver diseases†

    Primary biliary cholangitis as a roadmap for the development of novel treatments for cholestatic liver diseases† mā Frederik Nevens, Michael Trauner, Michael P. Manns

    I whakaputaina 2022
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Ambulatory 24 hour intraoesophageal pH and pressure recordings v provocation tests in the diagnosis of chest pain of oesophageal origin.

    Ambulatory 24 hour intraoesophageal pH and pressure recordings v provocation tests in the diagnosis of chest pain of oesophageal origin. mā G. Ghillebert, J. Janssens, Gaston Vantrappen, Frederik Nevens, Jan Piessens

    I whakaputaina 1990
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Variceal pressure is a factor predicting the risk of a first variceal bleeding: A prospective cohort study in cirrhotic patients

    Variceal pressure is a factor predicting the risk of a first variceal bleeding: A prospective cohort study in cirrhotic patients mā Frederik Nevens, Rami Bustami, Ilse Scheys, Emmanuel Lesaffre, Johan Fevery

    I whakaputaina 1998
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation

    Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation mā Bruno Roche, A.M. Roque-Afonso, Frederik Nevens, Didier Samuel

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Global genotype distribution of hepatitis C viral infection among people who inject drugs

    Global genotype distribution of hepatitis C viral infection among people who inject drugs mā Geert Robaeys, Rob Bielen, Darush Ghezel Azar, Homie Razavi, Frederik Nevens

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Review article: non‐biological liver support in liver failure

    Review article: non‐biological liver support in liver failure mā Wim Laleman, Alexander Wilmer, Pieter Evenepoel, Chris Verslype, Johan Fevery, Frederik Nevens

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Setanaxib, a first‐in‐class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo‐controlled, phase 2 trial

    Setanaxib, a first‐in‐class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo‐controlled, phase 2 trial mā Pietro Invernizzi, Marco Carbone, David Jones, Cynthia Levy, Nicola Little, Philippe Wiesel, Frederik Nevens

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Pretransplant Predictors of Posttransplant Adherence and Clinical Outcome: An Evidence Base for Pretransplant Psychosocial Screening

    Pretransplant Predictors of Posttransplant Adherence and Clinical Outcome: An Evidence Base for Pretransplant Psychosocial Screening mā Fabienne Dobbels, Johan Vanhaecke, Lieven Dupont, Frederik Nevens, Geert M. Verleden, Jacques Pirenne, Sabina De Geest

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Acute hepatitis B notification rates in Flanders, Belgium, 2009 to 2017

    Acute hepatitis B notification rates in Flanders, Belgium, 2009 to 2017 mā Özgür M. Koc, Pierre Van Damme, Dana Busschots, Rob Bielen, An-Marie Forier, Frederik Nevens, Geert Robaeys

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Review article: blood platelet number and function in chronic liver disease and cirrhosis

    Review article: blood platelet number and function in chronic liver disease and cirrhosis mā Peter Witters, Kathleen Freson, Chris Verslype, K. Peerlinck, Marc Hoylaerts, Frederik Nevens, Chris Van Geet, David Cassiman

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial

    Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial mā David Jones, Marco Carbone, Pietro Invernizzi, Nicola Little, Frederik Nevens, Mark G. Swain, Philippe Wiesel, Cynthia Levy

    I whakaputaina 2023
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase

    Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase mā Jonel Trebicka, Martin Hennenberg, Wim Laleman, Nataliya Shelest, Erwin Biecker, Michael Schepke, Frederik Nevens, Tilman Sauerbruch, Jörg Heller

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Patients with large‐duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without <scp>IBD</scp>

    Patients with large‐duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without <scp>IBD</scp> mā Johan Fevery, W. Van Steenbergen, Jos van Pelt, Wim Laleman, Ilse Hoffman, Karel Geboes, Séverine Vermeire, Frederik Nevens

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure.

    Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver fail... mā Wim Laleman, Alexander Wilmer, Pieter Evenepoel, Ingrid Vander Elst, Marcel Zeegers, Zahur Zaman, Chris Verslype, Johan Fevery, Frederik Nevens

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions

    Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions mā Wim Laleman, Len Verbeke, Philippe Meersseman, Joost Wauters, Jos van Pelt, David Cassiman, Alexander Wilmer, Chris Verslype, Frederik Nevens

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Return to Work and Social Participation: Does Type of Organ Transplantation Matter?

    Return to Work and Social Participation: Does Type of Organ Transplantation Matter? mā Christa De Baere, Dirk Delva, Annemie Kloeck, Kathleen Remans, Yves Vanrenterghem, Geert M. Verleden, Johan Vanhaecke, Frederik Nevens, Fabienne Dobbels

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Lamivudine therapy for chronic hepatitis B: A six-month randomized dose- ranging study

    Lamivudine therapy for chronic hepatitis B: A six-month randomized dose- ranging study mā Frederik Nevens, Janice Main, Pieter Honkoop, DL Tyrrell, Judy Barber, Mark Sullivan, Johan Fevery, RA De Man, H.C. Thomas

    I whakaputaina 1997
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    A Randomized Phase II Study of Drug-Eluting Beads versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma

    A Randomized Phase II Study of Drug-Eluting Beads versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma mā Hannah van Malenstein, Geert Maleux, Vincent Vandecaveye, Sam Heye, Wim Laleman, Jos van Pelt, Johan Vaninbroukx, Frederik Nevens, Chris Verslype

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Acute-on-chronic liver failure in cirrhosis

    Acute-on-chronic liver failure in cirrhosis mā Vicente Arroyo, Richard Moreau, Patrick S. Kamath, Rajiv Jalan, Pere Ginès, Frederik Nevens, Javier Fernández, Uyen To, Guadalupe García–Tsao, Bernd Schnabl

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: